Pfizer (PFE) Prepaid Assets (2009 - 2026)
Pfizer (PFE) posted quarterly Prepaid Assets of $2.9 billion for Q1 2026, down 1.32% year-over-year from $2.9 billion in Q1 2025, and up 3.56% quarter-over-quarter from $2.8 billion in Q4 2025.
Pfizer (PFE) Prepaid Assets (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Prepaid Assets for 16 consecutive years, with $2.9 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 1.32% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $2.9 billion (down 1.32% YoY), while the FY2025 annual figure was $2.8 billion, down 33.98% from the prior year.
- Prepaid Assets improved to $2.9 billion in Q1 2026 per PFE's latest filing, from $2.8 billion in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.0 billion in Q3 2022 and bottomed at $2.4 billion in Q3 2025.
- Historically, Prepaid Assets has averaged $4.0 billion across 5 years, with a median of $4.2 billion in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 56.36% — and 2025, when it tumbled 38.83%.
- Pfizer's Prepaid Assets stood at $5.0 billion in 2022, then dropped by 2.11% to $4.9 billion in 2023, then retreated by 13.4% to $4.3 billion in 2024, then plunged by 33.98% to $2.8 billion in 2025, then grew by 3.56% to $2.9 billion in 2026.
- Business Quant data shows PFE's Prepaid Assets at $2.9 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 3.52 Bn |
| Mar 29, 2026 | 2.91 Bn |
| Dec 31, 2025 | 2.81 Bn |
| Sep 28, 2025 | 2.36 Bn |
| Jun 29, 2025 | 2.69 Bn |
| Mar 30, 2025 | 2.95 Bn |
| Dec 31, 2024 | 4.25 Bn |
| Sep 29, 2024 | 3.86 Bn |
| Jun 30, 2024 | 4.19 Bn |
| Mar 31, 2024 | 4.37 Bn |
| Dec 31, 2023 | 4.91 Bn |
| Jul 2, 2023 | 4.83 Bn |
| Apr 2, 2023 | 5.12 Bn |
| Dec 31, 2022 | 5.02 Bn |
| Jul 3, 2022 | 5.97 Bn |
| Apr 3, 2022 | 4.20 Bn |
| Dec 31, 2021 | 3.82 Bn |
| Oct 3, 2021 | 3.79 Bn |
| Jul 4, 2021 | 3.82 Bn |
| Apr 4, 2021 | 4.09 Bn |